As-needed (PRN) post-hospitalization follow-up for Soft Tissue Infections

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Packard at El Camino Hospital, Mountain View, CA
Soft Tissue Infections+5 More
As-needed follow up - Behavioral
Eligibility
< 65
All Sexes
What conditions do you have?
Select

Study Summary

Compare the effectiveness of automatic vs as-needed (PRN) post-hospitalization follow-up for children who are hospitalized for common infections.

Eligible Conditions

  • Soft Tissue Infections
  • Pneumonia
  • Gastroenteritis
  • Urinary Tract Infections

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Soft Tissue Infections

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Within 7 days of hospital discharge

Day 7
Child health-related quality of life
Parent anxiety
Parent self-efficacy
Satisfaction with care
Day 14
Child time
Cost burden
Hospital readmission
Hospital readmissions related to the index infection
Medical errors
Medical interventions
Medical interventions related to the index infection
Parent time
Telephone and electronic communications with medical providers
Day 30
Non-primary care ambulatory visits
Total additional ambulatory visits
Month 6
Immunizations
Usual place of medical care
Well-child visits
Day 7
Symptom duration

Trial Safety

Safety Progress

1 of 3

Other trials for Soft Tissue Infections

Trial Design

2 Treatment Groups

Automatic post-hospitalization follow-up
1 of 2
As-needed (PRN) post-hospitalization follow-up
1 of 2
Active Control
Experimental Treatment

2674 Total Participants · 2 Treatment Groups

Primary Treatment: As-needed (PRN) post-hospitalization follow-up · No Placebo Group · N/A

As-needed (PRN) post-hospitalization follow-up
Behavioral
Experimental Group · 1 Intervention: As-needed follow up · Intervention Types: Behavioral
Automatic post-hospitalization follow-up
Behavioral
ActiveComparator Group · 1 Intervention: Automatic follow-up · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: within 7 days of hospital discharge

Trial Background

Prof. Eric Coon, Associate Professor
Principal Investigator
University of Utah
Closest Location: Packard at El Camino Hospital · Mountain View, CA
N/AFirst Recorded Clinical Trial
1 TrialsResearching Soft Tissue Infections
0 CompletedClinical Trials

Eligibility Criteria

Age < 65 · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are under the age of 18 years.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.